Vivani Medical, Inc. (VANI)

Market Cap	101.76M +66.8%
Revenue (ttm)	n/a
Net Income	-27.09M
EPS	-0.40
Shares Out	86.24M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,063
Open	1.160
Previous Close	1.150
Day's Range	1.160 - 1.200
52-Week Range	0.923 - 1.920
Beta	3.37
Analysts	Strong Buy
Price Target	4.83 (+309.32%)
Earnings Date	May 13, 2026

About VANI

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutid...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Nov 19, 2014
• Employees: 42
• Stock Exchange: NASDAQ
• Ticker Symbol: VANI
• Website: https://www.vivani.com

Analyst Summary

According to 3 analysts, the average rating for VANI stock is "Strong Buy." The 12-month stock price target is $4.83, which is an increase of 309.32% from the latest price.

Price Target

$4.83

(309.32% upside)

Analyst Consensus: Strong Buy